Concepedia

Author

Jane B. Trepel

National Cancer InstituteORCID

Also Known As

Arthur B. Pardee, J B Trepel, J TREPEL, J Trepel, J. B. TREPEL, J. B. Trepel, J. TREPEL, J. Trepel, J.B. Trepel, JANE TREPEL

662

Publications

24.4K

Citations

86

H-Index

175

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthCenter for Cancer ResearchGeorgetown University
JB

About

Jane B. Trepel is an author at National Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

58

120

10.8K

2

Natural Sciences

18

22

1.7K

3

Health Sciences

6

6

312

4

Engineering

4

4

413

5

Social Sciences

1

1

28

Jane B. Trepel

×

230

Publications

20.5K

Citations

81

H-Index

YearCitations

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Jennifer S. Isaacs, Yun Jin Jung, David R. Mole,

Cancer Cell

2005

935

IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesis

Yunjin Jung, Jennifer S. Isaacs, Sunmin Lee,

The FASEB Journal

2003

664

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

Denise A. Yardley, Roohi Ismail‐Khan, Bohuslav Melichar,

Journal of Clinical Oncology

2013

410

Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma

Qin Ryan, Donna Headlee, Milin Acharya,

Journal of Clinical Oncology

2005

406

The hsp90-related Protein TRAP1 Is a Mitochondrial Protein with Distinct Functional Properties

Sara J. Felts, Barbara Owen, Phuongmai Nguyen,

Journal of Biological Chemistry

2000

367

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins,

PubMed

1996

361

Curcumin is an Inhibitor of p300 Histone Acetylatransferase

Len Neckers, Jane B. Trepel, Sunmin Lee,

Medicinal Chemistry

2006

302

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan,

Journal for ImmunoTherapy of Cancer

2018

295

Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis

Soichiro Yoshida, Shinji Tsutsumi, Guillaume Mühlebach,

Proceedings of the National Academy of Sciences

2013

293

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Anish Thomas, Arun Rajan, Arlene Berman,

The Lancet Oncology

2015

293

Page 1